Articles tagged with “antimicrobial-resistance”

Eli Lilly $3.8B Vaccine Acquisitions: Infectious Disease R&D

Examine Eli Lilly's $3.8B acquisition of three biotechs to build an infectious disease vaccine pipeline targeting shingles, EBV, and resistant bacteria.

35 min read

5/28/2026

eli lilly vaccine acquisitions infectious disease antimicrobial resistance shingles vaccine ebv vaccine pharma strategy biopharma pipeline

Generative AI Antibiotic Discovery: Gram-Negative Pathogens

Analyze the application of generative AI in antibiotic discovery. This report examines the Phare Bio-Basilea partnership and Gram-negative drug development.

30 min read

4/17/2026

generative ai antibiotic discovery gram-negative bacteria drug development antimicrobial resistance machine learning de novo design pharmacology